test

James Silverman

@Opaleye Management Inc.

Latest period2024 - Q3ReportedManaged Assets$599.558MTotal holdings44
Assets growth rate37%Assets growth rate (2-Q avg)16.19%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Opaleye Management Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 44 positions.

Assets under management

The assets under management (AUM) of Opaleye Management Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 599.558M in assets, with a quarterly growth rate of 37% and a 2-quarter average growth rate of 16.19%. The portfolio is managed by James Silverman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
FDMT4d Molecular Therapeutics Inc
Recent Activity
Exited
0%
$7.257M
345,750 shares@ $21.0 avg price
IOVAIovance Biotherapeutics Inc
Recent Activity
Exited
0%
$7.194M
897,000 shares@ $8.02 avg price
NTLAIntellia Therapeutics Inc
Recent Activity
Exited
0%
$4.879M
218,000 shares@ $22.38 avg price
LXRXLexicon Pharmaceuticals Inc
Recent Activity
Exited
0%
$3.15M
1.875M shares@ $1.68 avg price
SVRASavara Inc
Recent Activity
Exited
0%
$2.881M
714,960 shares@ $4.04 avg price
VTYXVentyx Biosciences Inc
Recent Activity
Exited
0%
$2.749M
1.19M shares@ $2.31 avg price
VSTMVerastem Inc
Recent Activity
Exited
0%
$2.727M
915,000 shares@ $2.98 avg price
FULCFulcrum Therapeutics Inc
Recent Activity
Exited
0%
$1.767M
285,000 shares@ $6.2 avg price
KPTIKaryopharm Therapeutics Inc
Recent Activity
Exited
0%
$1.236M
1.425M shares@ $0.87 avg price
PMVPPmv Pharmaceuticals Inc
Recent Activity
Exited
0%
$769,500
475,000 shares@ $1.62 avg price